Personalized cancer vaccines

Show results for

Unknown (376)
Genomics (54)
Proteomics (52)
Transcriptomics (10)
Clinical (3)
Genomic (1)
Other (1)

Organisms

Homo sapiens (57)
Mus musculus (25)
Bos taurus (16)
Bothrops moojeni (16)
Dermestes lardarius (16)
Frangula alnus (16)
Gallus gallus (16)
Gossypium hirsutum (16)
Megathura crenulata (16)
Ovis aries (16)
Pachymenia carnosa (16)
Pandalus borealis (16)
Quercus alba (16)
Rhodotorula (16)
Senegalia senegal (16)
Medicago sativa (10)
Rattus rattus (1)

Organisms

Homo sapiens (35)
Mus musculus (7)

Repository

ENA (50)
geo (27)
biostudies-arrayexpress (16)
pride (15)
EGA (4)
iProX (3)
MassIVE (2)
dbGaP (1)

Tissue

Blood (7)
Bone marrow (5)
Mononuclear cell (5)
Peripheral blood mononuclear cell (4)
Colon (2)
B cell (1)
Blood plasma (1)
Brain (1)
Cell culture (1)
Ovary (1)

Disease

Acute myeloid leukemia (5)
Chronic lymphocytic leukemia (3)
Brain cancer (2)
Neoplasm Metastasis (1)
Adenocarcinoma (1)
Colorectal Neoplasms (1)
Colon adenocarcinoma (1)
Colon cancer (1)
Ovarian carcinoma (1)

Technology Type

Mass Spectrometry (15)
Shotgun proteomics (10)
Bottom-up proteomics (3)
Affinity purification coupled with mass spectrometry proteomics (2)
Immunopeptidomics (2)
Data-dependent acquisition (1)

Instrument Platform

Orbitrap Fusion Lumos (2)
Q Exactive HF (1)
TimsTOF Pro 2 (1)

Publication Date

2015 (16)
2013 (16)
2021 (7)
2026 (5)
2025 (5)
2024 (4)
2022 (4)
2023 (3)
2020 (2)
2019 (1)

First Public Date

2026 (10)
2015 (8)
2014 (8)
2025 (5)
2023 (5)
2022 (5)
2024 (4)
2021 (2)
2018 (2)
2020 (1)

Study status

Completed (2)
Recruiting (1)

Study type

Proteomic profiling by array (16)
Interventional (2)
Observational (1)

Release Date

2023 (56)
2022 (56)
2025 (55)
2021 (50)
2024 (45)
2020 (35)
2019 (26)
2018 (18)
2017 (16)
2015 (14)
2013 (9)
2016 (5)
2026 (3)
2014 (2)
2012 (1)
2011 (1)

Lab affiliation

Institute for Research in Immunology and Cancer, Department of Biochemistry, Department of Chemistry, Université de Montréal, Québec, Canada H3T 1J4 (5)
Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany (2)
Center of experimental therapeutics Department of oncology UNIL CHUV Ludwig Institute for Cancer Research Lausanne Centre de recherche Agora Rue du Bugnon 25A CH-1005 Lausanne (1)
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany (1)
Dep. of Oncology-Pathology, Karolinska Institutet, Scilifelab, Stockholm, Sweden (1)
Department of Peptide-based Immunotherapy (1)
Dept. of Computer Science, University of Tübingen Germany, Center for Bioinformatics, University of Tübingen, Germany, Quantitative Biology Center, University of Tübingen, Germany, Max Planck Institute for Developmental Biology, Germany, (1)
German Cancer Reseach Center (DKFZ) (1)
Institute for Research in Immunology and Cancer, Department of Chemistry, Université de Montréal, Montréal, Québec, Canada H3T 1J4 (1)
OmicScouts GmbH Lise-Meitner-Str. 30 D-85354 Freising Germany (1)

Location

United States (3)

Keyword

Vaccines (2)
All types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation (1)
Imiquimod (1)
Neoantigen cancer vaccine (1)
Personalized neoantigen cancer vaccine (1)
GI cancer (1)
Kidney cancer (1)
Pembrolizumab (1)

Previous page
1 / 50
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 50
Next page

Sort by:

Relevance

Page size

Iimmunopeptidomics pipeline for generation of personalized oncolytic cancer vaccines.

We used a streamlined pipeline for the generation of personalized cancer vaccines starting from the isolation and selection of the most immunogenic peptide candidates expressed on the tumour cells and ending in the generation of efficient therapeutic oncolytic cancer vaccines. We used MHC-I immunoaf...

ORGANISM(S): Mus musculus (Mouse)

2022-04-06 | PXD026463 | Pride